Qure.ai

qXR, a class II CE approved medical device, detects and localises 20+ abnormalities on a CXR including the presence of lung nodules. qXR is intended to support consultant radiologists and reporting radiographers in clinical decision making. It is an automated chest x-ray AI algorithm to improve efficiency, accuracy and turnaround time (TAT) in reporting CXRs. QXR is deployed in more than 30+ countries for multiple disease applications including Tuberculosis, COVID-19 and Lung cancer. With two US patents for the product and several validation studies published in leading journals like The Lancet, qXR has proven to be accurately identifying the abnormalities in the lung, in a few minutes.